Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 17, 2025
Health-related quality of life and economic impacts in adults with sickle cell disease with recurrent vaso-occlusive crises: findings from a prospective longitudinal real-world surveyJennifer Drahos, Adriana Boateng-Kuffour, Melanie Calvert, et al.
Journal of Medical Economics|February 16, 2021
Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic modelNanxin Li, Eileen K Sawyer, Konrad Maruszczyk, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 17, 2025
Health-related quality of life and economic impacts in adults with transfusion-dependent β-thalassemia: findings from a prospective longitudinal real-world studyJennifer Drahos, Adriana Boateng-Kuffour, Melanie Calvert, et al.
Drugs - Real World Outcomes|November 20, 2025
Health Equity Concerns in People with Sickle Cell Disease and Recurrent Vaso-Occlusive Crises: Results from an International Survey StudyAdriana Boateng-Kuffour, Lauren Lilly, Jennifer Drahos, et al.
PLOS Mental Health|February 9, 2026
An examination of inpatient ward and secondary community care stay costs for individuals with complex mental health needs in the UKPooja Saini, Antony P Martin, Jason C McIntyre, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2021
Evidence of a disability paradox in patient-reported outcomes in haemophiliaJamie O'Hara, Antony P Martin, Diane Nugent, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 27, 2017
The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, SerbiaTanja Novakovic, Antony P Martin, Mark Parker, et al.
Value in Health Regional Issues|December 4, 2022
Economic Evaluation of Immune Tolerance Induction in Children With Severe Hemophilia A and High-Responding Inhibitors: A Cost-Effectiveness Analysis of Prophylaxis With EmicizumabRicardo Mesquita Camelo, Mariana Michel Barbosa, Maiara Silva Araújo, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 29, 2022
Health state utilities for beta-thalassemia: a time trade-off studyAntony P Martin, Enrico Ferri Grazzi, Claudia Mighiu, et al.
Journal of Comparative Effectiveness Research|July 9, 2021
Evidence-based public policy making for medicines across countries: findings and implications for the futureBrian Godman, Joseph Fadare, Hye-Young Kwon, et al.
Pageof 5